151 related articles for article (PubMed ID: 30777405)
1. Longitudinal kidney function trajectories predict major bleeding, hospitalization and death in patients with atrial fibrillation and chronic kidney disease.
Posch F; Ay C; Stöger H; Kreutz R; Beyer-Westendorf J
Int J Cardiol; 2019 May; 282():47-52. PubMed ID: 30777405
[TBL] [Abstract][Full Text] [Related]
2. The CHA
Beyer-Westendorf J; Kreutz R; Posch F; Ay C
Int J Cardiol; 2018 Feb; 253():71-77. PubMed ID: 29306476
[TBL] [Abstract][Full Text] [Related]
3. Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation.
Jun M; James MT; Ma Z; Zhang J; Tonelli M; McAlister FA; Manns BJ; Ravani P; Quinn RR; Wiebe N; Perkovic V; Wilton SB; Winkelmayer WC; Hemmelgarn BR;
Am J Kidney Dis; 2017 Jun; 69(6):734-743. PubMed ID: 27998624
[TBL] [Abstract][Full Text] [Related]
4. Estimated GFR Trajectories of People Entering CKD Stage 4 and Subsequent Kidney Disease Outcomes and Mortality.
Xie Y; Bowe B; Xian H; Balasubramanian S; Al-Aly Z
Am J Kidney Dis; 2016 Aug; 68(2):219-228. PubMed ID: 26948835
[TBL] [Abstract][Full Text] [Related]
5. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T
JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776
[TBL] [Abstract][Full Text] [Related]
6. Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease.
Pastori D; Pignatelli P; Perticone F; Sciacqua A; Carnevale R; Farcomeni A; Basili S; Corazza GR; Davì G; Lip GYH; Violi F;
Int J Cardiol; 2016 Nov; 223():619-624. PubMed ID: 27565838
[TBL] [Abstract][Full Text] [Related]
7. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
[TBL] [Abstract][Full Text] [Related]
8. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
[TBL] [Abstract][Full Text] [Related]
9. The association between atrial fibrillation and in-hospital outcomes in chronic kidney disease patients with acute coronary syndrome: findings from the improving care for cardiovascular disease in China-acute coronary syndrome (CCC-ACS) project.
Yang L; Ye N; Wang G; Bian W; Xu F; Zhao D; Liu J; Hao Y; Liu J; Yang N; Cheng H;
BMC Cardiovasc Disord; 2021 Jul; 21(1):345. PubMed ID: 34273963
[TBL] [Abstract][Full Text] [Related]
10. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.
Fox KAA; Lucas JE; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Kayani G; Oto A; Mantovani LG; Misselwitz F; Piccini JP; Turpie AGG; Verheugt FWA; Kakkar AK;
BMJ Open; 2017 Dec; 7(12):e017157. PubMed ID: 29273652
[TBL] [Abstract][Full Text] [Related]
11. Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation.
Guo Y; Wang H; Zhao X; Zhang Y; Zhang D; Ma J; Wang Y; Lip GY
Int J Cardiol; 2013 Oct; 168(5):4678-84. PubMed ID: 23972369
[TBL] [Abstract][Full Text] [Related]
12. Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry.
Deng H; Shantsila A; Xue Y; Bai Y; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Wu S; Lip GYH
Arch Cardiovasc Dis; 2019; 112(6-7):420-429. PubMed ID: 31133543
[TBL] [Abstract][Full Text] [Related]
13. Improvement in estimated glomerular filtration rate in patients with chronic kidney disease undergoing catheter ablation for atrial fibrillation.
Navaravong L; Barakat M; Burgon N; Mahnkopf C; Koopmann M; Ranjan R; Kholmovski E; Marrouche N; Akoum N
J Cardiovasc Electrophysiol; 2015 Jan; 26(1):21-7. PubMed ID: 25142836
[TBL] [Abstract][Full Text] [Related]
14. Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial Fibrillation.
Hijazi Z; Granger CB; Hohnloser SH; Westerbergh J; Lindbäck J; Alexander JH; Keltai M; Parkhomenko A; López-Sendón JL; Lopes RD; Siegbahn A; Wallentin L
J Am Heart Assoc; 2020 Sep; 9(18):e017155. PubMed ID: 32865097
[TBL] [Abstract][Full Text] [Related]
15. Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney Disease, and Mortality Among Patients With a Decreased Estimated GFR.
Massicotte-Azarniouch D; Kuwornu JP; Carrero JJ; Lam NN; Molnar AO; Zimmerman D; McCallum MK; Garg AX; Sood MM
Am J Kidney Dis; 2018 Feb; 71(2):191-199. PubMed ID: 29153994
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Fauchier L; Vourc'h P; Andres CR; Taillandier S; Halimi JM; Lip GYH
Chest; 2014 Jun; 145(6):1370-1382. PubMed ID: 24356875
[TBL] [Abstract][Full Text] [Related]
17. Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).
Roldán V; Marín F; Fernández H; Manzano-Fernández S; Gallego P; Valdés M; Vicente V; Lip GY
Am J Cardiol; 2013 Apr; 111(8):1159-64. PubMed ID: 23337836
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation.
Bassand JP; Accetta G; Al Mahmeed W; Corbalan R; Eikelboom J; Fitzmaurice DA; Fox KAA; Gao H; Goldhaber SZ; Goto S; Haas S; Kayani G; Pieper K; Turpie AGG; van Eickels M; Verheugt FWA; Kakkar AK;
PLoS One; 2018; 13(1):e0191592. PubMed ID: 29370229
[TBL] [Abstract][Full Text] [Related]
19. Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease.
Eikelboom JW; Connolly SJ; Gao P; Paolasso E; De Caterina R; Husted S; O'Donnell M; Yusuf S; Hart RG
J Stroke Cerebrovasc Dis; 2012 Aug; 21(6):429-35. PubMed ID: 22818021
[TBL] [Abstract][Full Text] [Related]
20. Thromboembolism and bleeding in patients with atrial fibrillation and stage 4 chronic kidney disease: impact of biomarkers.
Matusik PT; Leśniak WJ; Heleniak Z; Undas A
Kardiol Pol; 2021; 79(10):1086-1092. PubMed ID: 34392517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]